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Summary Study of general h&aelig;modynamics in 15
patients with low-renin essential hyper-
tension showed h&aelig;modynamic and pathophysiological
heterogeneity. However, there was suppression of sym-
pathetic nervous system function in all low-renin
patients, regardless of h&aelig;modynamic pattern. Subnor-
mal sympathetic nervous activity was manifested by a
low normal mean plasma-noradrenaline concentration
at rest, diminished noradrenaline responsiveness to pos-
tural stimulation, and a reduced blood-pressure response
to the indirectly acting sympathomimetic amine tyra-
mine. It is proposed that the syndrome of low-renin
essential hypertension is of diverse &aelig;tiology, but with
secondary sympathetic nervous system underactivity as
a feature common to the various forms. The low plasma-
renin activity is probably an expression of defective sym-
pathetic nervous system stimulation of renin release.
Introduction
SOME patients with essential hypertension have low
plasma-renin activity (P.R.A.).l 2 Despite continuing in-
vestigative interest, the pathophysiology of these "low-
renin hypertensives" remains uncertain. There are prob-
ably several distinct mechanisms responsible for the
renin suppression in this syndrome. Excessive adrenal
mineralocorticoid secretion 3 4 increased central ("effec-
tive") blood-volume, 6 and progressive reduction in
P.R.A. with time in severe or longstanding essential
hypertension 7 have all been found.
Since the sympathetic nervous system has an impor-
tant modulating influence on renin release,9 it seemed
possible that the final common pathway for renin sup-
pression in the various forms of low-renin hypertension
might be sympathetic nervous system underactivity.8 10
This possibility was explored using biochemical and
pharmacological indices of sympathetic nervous system
function.
Patients
Thirty-two hypertensive patients were recruited from the
hypertensive and endocrinology services of the University
of .Michigan Medical Center. All were male and aged between
20 and 50 years. Average casual blood-pressure was above 155
mm Hg systolic or 95 mm Hg diastolic, or both. Investigations
performed, including estimation of urinary aldosterone excre-
tion, adequately excluded a diagnosis of secondary hyperten-
sion. The renin status of the hypertensives was categorised as
"normal" or "low" by reference of P.R.A. values on an unre-
stricted diet, after 1 h standing, and 24 h urinary sodium ex-
cretion (urine collection in a metabolic ward), to renin and
sodium values in forty-one age-matched normal male volun-
teers." P.R.A. was measured using a radioimmunoassay of
angiotensin i generated in vitro. 12 All hypertensives and twelve
of the normal subjects were recruited into the study now to be
described. All subjects read and signed an informed consent
form outlining the details of the tests to be performed.
Materials and Methods
Measurement of general haemodynamics and blood-volumes
was done at rest in all subjects, after they had remained recum-
bent in hospital overnight, using methods previously de-
scribed.13 Cardiac output was measured by dye dilution, intra-
arterial blood-pressure was recorded after percutaneous
puncture of the brachial artery, central (effective) blood-
volume was derived from the cardiac output and mean transit
time of the indicator dye,13 with dye delivery into the right
atrium via a Swan-Ganz catheter and dye sampling from the
brachial artery. Plasma volume was estimated using Evans
blue. From this, and the arterial haematocrit, total blood-
volume was calculated.
Sympathetic nervous system function was then studied in
ten of the hypertensive patients with normal p.R.A., in eight pa-
tients with low P.R.A., and in eight normal subjects. All investi-
gations were carried out with subjects in sodium balance, after
a minimum of 5 days on a sodium intake of 160 mmol daily
in a metabolic ward. Plasma-noradrenaline concentration in
venous blood was measured by the fluorimetric assay of Ren-
zini et al.14 after a 2 h supine rest and after 12 min of 35&deg;
head-up tilting on a tilt-table. Plasma-noradrenaline was esti-
mated blind by one of us (V. DeQ.) without knowledge of the
diagnosis.
Next the intra-arterial blood-pressure-response to the sym-
pathomimetic agent tyramine was studied. Tyramine is an in-
directly acting amine, having pressor activity only through its
ability to release noradrenaline from sympathetic nerve end-
ings.15 Tyramine hydrochloride was administered by rapid in-
travenous injection in doses of 0-75 mg, 1-5 mg, and 2.5 mg.
Blocking doses of propranolol (0.2 mg/kg) and atropine (0-04
mg/kg) were administered before tyramine to abolish tyramine
effects on the heart and reflex cardiac responses to the change
in blood-pressure produced by the drug: with this experimental
design the blood-pressure rise with tyramine was solely depen-
dent on noradrenergic vasoconstriction. The blood-pressure re-
sponse to intravenous bolus injections of noradrenahne in
doses of 1, 2, and 3 fig was then recorded in each patient for
comparison with the tyramine responses.
On 2 other days the P.R.A. response to exogenous adrenergic
stimulation was studied, using the jj-adrenergic agonist iso-
prenaline. Isoprenaline stimulates renin release in man, prob-
ably by direct action on receptors of the juxtaglomerular
cells of the kidney.16 Isoprenaline hydrochloride was infused at
a rate of 30 ng base/kg/min for 25 min, with sequential sam-
pling of venous blood for estimation of P.R.A. during the infu-
sion. The drug was administered twice to each subject, during
the 160 mmol sodium diet, then under conditions of sodium
deprivation (sodium intake 10 mmol daily for 6 days).
Results
Hcemodynamics
Haemodynamic findings at rest are shown in the
accompanying table. Overall the low-renin essential
hypertensives were characterised as a group by a normal
cardiac output, the higher blood-pressure being main-
tained by an elevated total peripheral vascular resis-
tance. Heart-rate was marginally, but not significantly,
lower than in the normal subjects (table). The mean
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HAEMODYNAMICS AT REST (MEAN +S.D.)
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’the significance levels of the differences between normal subjects and the lypertensme groups are shown. *P< ,0.05, tp <0.01 (Student’s t test).
haemodynamic values, however, obscure an underlying
haemodynamic heterogeneity. Three haemodynamic pat-
terns were recognised. Severe hypertension (resting
mean blood-pressure greater than 125 mm Hg) was pres-
ent in four patients (fig. 1) who had a normal total
blood-volume, normal central blood-volume, normal or
low cardiac output, and elevated total peripheral vascu-
lar resistance. In six patients with mild hypertension and
normal total blood-volume, central (effective) blood-
volume was increased (fig. 1), with a raised stroke volume
and cardiac output (Y<005). The remaining five pa-
tients with low P.R.A. had a normal central and total
blood-volume, normal cardiac output, and elevated total
peripheral resistance as the basis for their mild to
moderately severe disease.
Fig. I-Arterial pressure and blood-volumes in normal and low-renin
hypertensives compared with normal subjects.
Mean values and S.D.s are shown. *p<O.05, tf<0-01.
Plasma-noradrenaline Concentration
Plasma-noradrenaline in normal subjects at rest was
136&plusmn;44 ng/1 (mean&plusmn;s.D.) (fig. 2). In hypertensives with
normal renin, plasma-noradrenaline was 173&plusmn;73 ng/1
(difference not significant). In the low-renin essential
hypertensives, plasma-noradrenaline at rest was 98:!::63
ng/1. This was significantly lower than in hypertensives
with normal P.R.A. (p<0.05). Mean plasma-noradrena-
line was approximately 30% lower in the low-renin
hypertensives than in normal subjects, but the difference
was not significant (P>0.05). However, in three of eight
low-renin patients, plasma-noradrenaline was below
normal (fig. 2).
Low-renin hypertensives where characterised as a
group by diminished sympathetic responsiveness to
head-up tilting. In three of eight a vasovagal reaction
occurred. There was no change in plasma-noradrenaline
with tilting overall (+2&plusmn;102 ng/1) (fig. 2). Normal sub-
jects and hypertensives with normal P.R.A. both demon-
strated approximately a doubling of plasma-noradrena-
line with tilting (fig. 2).
Blood-pressure Response to Tyramine
The rise in blood-pressure with tyramine was
diminished in the low-renin hypertensives (fig. 3). At
each of the three doses of tyramine used, the pressor re-
Fig. 2-Plasma-noradrenaline resting and tilted.
Subjects (A) had a vasovagal reaction with tilting, and resting nor-
adrenaline values only are available. Plasma-noradrenaline rose with
tilting in normal subjects and hypertensives with normal plasma-renin
f*p 0.01, paired t test).
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sponse in the low-renin hypertensives was approximately
only 30% of that in the other two groups (P<0.02). The
rise in blood-pressure produced by intravenous injection
of noradrenaline was normal in the patients with low
P.R.A.
Renin Response to Exogenous Adrenergic Stimulation
The P.R.A. response to isoprenaline on the 160 mmol
sodium diet was marginally, but not significantly, lower
in hypertensives with normal renin than in normal sub-
jects (fig. 4). In the low-renin patients, the renin re-
sponse to isoprenaline was approximately 50% of normal
(P<0.05). This was not an expression of a. generalised
reduction in [-adrenergic receptor sensitivity in low-
renin hypertensives, since the heart-rate response to iso-
prenaline was unimpaired (fig. 4). On the low-salt diet,
the P.R.A. response was normal in the normal-renin
hypertensives, but clearly subnormal in the low-renin
patients (approximately 80% reduced, P<0.01).
Fig. 3-Blood-pressure responses to tyramine and noradrenaline (after
cardiac autonomic blockade with propranolol plus atropine) in hyper-
tensive patients compared with normal subjects.
&bullet;Normal subjects
o=Essenl1al hypertension, normal renin.
-=Essential hypertension, low renin.
0.02.
Discussion
The sympathetic nervous system plays an important
role in the control of renin release by the kidney. This
knowledge led to the early suggestion that P.R.A. and
sympathetic nervous function may be closely linked in
human hypertension.17 For patients with mild essential
hypertension and elevated P.R.A. this concept now seems
established. There is accumulating evidence that in such
patients sympathetic nervous system overactivity exists,
raising P.R.A. and sustaining the rise in blood-pres-
sure. 8 17-19
For essential hypertensives with low P.R.A., sympa-
thetic nervous underactivity has been proposed as the
basis for the suppression of P.R.A.,8 10 but here the evi-
dence is less convincing, although improving.8 20 In the
present study, using biochemical and pharmacological
indices of sympathetic nervous system function, we
found striking evidence of sympathetic nervous underac-
tivity in patients with low-renin essential hypertension.
Fig. 4-Changes in P.R.A. and heart-rate with isoprenaline in hyperten-
sive patients compared with normal subjects.
&bullet;=Normal subjects.
o=Essential hypertension, normal renm
D=Essentiat hypertension, low remn.
*p<0.05; P<0.01.
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While the plasma-noradrenaline concentration at rest
was subnormal in only a minority of low-renin patients,
the noradrenaline response to postural stimulation was
much diminished, and the blood-pressure rise with the
indirectly acting sympathomimetic amine tyramine was
clearly attenuated. Tyramine produces raised blood-
pressure by releasing the sympathetic neurotransmitter
noradrenaline from sympathetic nerve varicosities, and
has been used as a pharmacological tool in the study of
sympathetic nerve endings.15 The pressor response to
tyramine is related to the noradrenaline pool size in the
sympathetic nerve ending. 15 Since the blood-pressure re-
sponse to intravenous administration of noradrenaline
in the low-renin hypertensives was normal, the findings
with tyramine suggest either diminished accessibility of
tyramine to the sympathetic noradrenaline pools, or,
more likely, a diminution in noradrenaline pool size.
With exogenous adrenergic stimulation of renin
release, using isoprenaline, the rise in P.R.A. was subnor-
mal in the low-renin hypertensives. This abnormality
was accentuated by dietary sodium restriction. There
are other reports also of a diminished renin response to
pharmacological stimulation with infusion of nor-
adrenaline 21 and theophylline 20 in low-renin hyperten-
sion. Therefore the defective sympathetic nervous stimu-
lation of renin release in low-renin essential
hypertension may involve two mechanisms: first, de-
creased sympathetic nerve traffic to the kidney; and
second, a reduction in responsiveness to adrenergic sti-
mulation.
Several different mechanisms have been implicated in
the pathogenesis of low-renin essential hypertension.
Mineralocorticoid excess,3 4 increased central (effective)
blood-volume,5 6 and a reduction in P.R.A. with time in
severe or longstanding essential hypertension 7 have all
been proposed as explanations of the lower plasma-
renin. The haemodynamic findings in low-renin essential
hypertension in this study were varied, suggesting such
a pathophysiological heterogeneity. In particular, cen-
tral blood-volume was increased, without an increase in
total blood-volume, in six patients, while four patients
had severe longstanding hypertension. Adrenal steroid
metabolism was not studied by us, so the existence of
non-aldosterone mineralocorticoid hypertension in some
of these patients is possible. 4
These different pathophysiological patterns may all be
associated with sympathetic nervous underactivity.
Reduced sympathetic responsiveness has been described
in severe, longstanding essential hypertension 22 23
although the mechanism is uncertain. Primary aldos-
teronism, which may be considered as the prototype of
human mineralocorticoid hypertension, is also associ-
ated with diminished sympathetic nervous responsive-
ness. 24 In hypertensives with an increase in central
blood-volume,5 6 sympathetic nervous underactivity
would be expected to follow from stimulation of cardio-
pulmonary volume receptors by the higher central
blood-volume.2’ 26 It is proposed that the syndrome of
low-renin essential hypertension is of diverse setiology,
but with secondary sympathetic nervous system un-
deractivity as a feature common to the various forms.
The low P.R.A. is probably an expression, at least in part,
of defective sympathetic nervous stimulation of renin
release.
Requests for reprints should be addressed to M. E., Hypertension
Section, Department of Internal Medicine, University ot Michigan
Medical Center, Ann Arbor, Michigan 48109, U.S.A.
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CIRRHOSIS IN SOUTH LONDON
H. J. F. HODGSON* R. P. H. THOMPSON
St. Thomas’ Hospital, London SE1
Summary Alcoholism was the major &aelig;tiological
factor in 65% of 78 patients presenting
with cirrhosis to a hospital in Central London during
1968-74. It is suggested that in the U.K. the importance
of alcoholism in patients with cirrhosis has been un-
derestimated.
Introduction
THERE is little agreement on the relative importance
of alcohol in the aetiology of cirrhosis of the liver in the
U.K. Surveys in 1966 and 1973 of patients with cir-
rhosis implicated alcoholism as the primary factor in
from 24%’ to 51 %2 of cases. This may be partly because
the relative importance of alcohol will vary between sur-
veys carried out in specialised centres and those in less
specialised district general hospital. Furthermore, the
consumption of alcohol in the U.K. has been steadily in-
creasing over the past 20 years,3 and so the contribution
made by alcohol to liver disease may be expected to rise.
"Present address: Department of Medicine, Royal Free Hospital, London NW1
